Information Links
Mims
Main Navigation
Drugs
Conditions
News and resources
MIMS HostedFeatured MIMS news
SGLT2 inhibitors summarised in new MIMS table
Prescribers can quickly compare key features and benefits...
Latest MIMS news
Live updates: Coronavirus (COVID-19) in the UK
Use our timeline to follow the latest coronavirus developments...
First COVID-19 vaccine approved for use in the UK from next week
The MHRA has approved the COVID-19 vaccine developed...
NICE recommends further migraine prevention option
Galcanezumab (Emgality) is the second calcitonin gene-related...
Proposed withdrawal of bipolar disorder treatment revoked
The manufacturer of first-line bipolar disorder treatment...
COVID-19 vaccine to be submitted for approval 'within days'
Pfizer and BioNTech say their COVID-19 vaccine has...
Most statin side-effects down to 'nocebo' effect, study suggests
90% of the symptom burden reported with statins was...
Diabetes drug approved to treat heart failure
Forxiga (dapagliflozin) is the first SGLT2 inhibitor...
Hopes rise for first COVID-19 vaccine as results show 'more than 90% efficacy'
Researchers from Pfizer and BioNTech have hailed preliminary...
New low-dose LABA/corticosteroid inhaler for asthma
A lower-dose metered-dose inhaler has been added to...
Licence Changes & Product Updates
MIMS Clinics
Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.
MIMS bulletins
News and updates straight to your inbox. Prescribing Update: Twice-weekly news bulletin
Alert: Urgent prescribing updates Clinics: Disease-themed monthly round-up